Factors associated with delayed diagnosis of breast cancer; a study in North-West of Iran

Fouladi, Nasrin; Barahman, Maedeh; Amani, F; Bahadoram, Mohammad; Eghbali, Sevda

doi:10.15171/ipp.2020.02

Cited by 11 publications

(12 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another study conductedby Nasrin and colleagues reported a mean age of 43.7 years with the maximum age of 71 and minimum age of 14 years and most women fell in the age bracket of 40 to 60 in her study While Bariati et al, patients aged above 59 were 50% in his study [3,7]. In our study, we found that 56% of patients reported a delay of more than 3 months and about 28% were at the early stage and 29% at the advanced stage while in Germany, the UK, and Columbia about 17% of patients reported similar delay [8].…”

Section: Discussionmentioning

confidence: 69%

“…Due to the high mortality rate in women, diagnostic procedures are of prime importance for breast cancers because many people visit for consultations in advance stages of the disease. Many people present late due to fear of cancer, educational background or lack of support from family and friends and some don't have access to medical facilities [3]. Breast cancer is examined by a visual inspection with patients sitting upright and changes in nipples, asymmetry, skin dimpling, erythema, and obvious masses are noted in the patient.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Factors Associated with Delayed Presentation among Women with Breast Cancer

Mangi

Bashir

Rahim

et al. 2021

JPRI

View full text Add to dashboard Cite

Purpose: Breast cancer in women is one of the most common tumors in women worldwide. Throughout Pakistan, there have been multiple reasons that cause a delay in the presentation of breast cancer and many reasons are neither reported nor studied. The objective of our study is to provide detailed estimates on the prevalence and causes of delays in order to plan targets for intervention. Materials Methods: This is a Quasi-Experimental study done at Department of General surgery, Shaheed Benazir Bhutto Medical College, Lyari Karachi from September 2018 to August 2020. We recorded the histories of 200 women by conducting structured interviews after their written consent and noted their mean age, standard deviation, early symptoms, and reasons for delayed presentation. Only patients who discovered their symptoms are included in the study.We then conducted the analysis on early and advanced stage patients using SPSS Version 20. Results: The mean patient's age was 44.2 ± 4.13years, where 200 females were observed with a maximum age of 70 years and minimum age of 20 years in our data. Approximately 49% of breast cancers were advanced stage and about 69% had a rural residence, while painless bump was observed in 91% of women,hospital distance was less and more than 60 minutes and that’s has hindered presentation too. Similarly, about 71.2% of breast cancer patients presented with advanced-stage disease. We observed the most common factor to be a painless lump and misdiagnosed first visit. Conclusion: Our study concludes that distance, rural residence, painless breast lump, and misdiagnosis are the most common reason of delay presentation by the patients and should be intervened.

show abstract

Section: Discussionmentioning

confidence: 69%

Section: Introductionmentioning

confidence: 99%

Factors Associated with Delayed Presentation among Women with Breast Cancer

Mangi

Bashir

Rahim

et al. 2021

JPRI

View full text Add to dashboard Cite

show abstract

“…Detailed information about each article is included in Table S1. The majority of articles reported on studies conducted in countries in Africa (32%), 22–37 followed by South‐East Asia (30%), 38–51,71 the Middle East (20%), 52–61 Latin America (16%), 62–69 and Eastern Europe (2%) 45,70 . Two articles reported on patients from more than one country 24,45 …”

Section: Resultsmentioning

confidence: 99%

“…Socio‐cultural variables related to longer patient intervals were explored in four articles and included vague symptom interpretation, 58 lack of knowledge about cancer and cancer symptoms, not believing that cancer is curable, being unfamiliar with breast self‐examination, 52 and use of complementary or alternative medicine 60 . One article documented effects of fear of cancer, spouse behavior, and carelessness on the patient interval but did not specify the direction or meaning of the effects (e.g., whether fear of cancer was related to longer or shorter patient intervals) 59 …”

Section: Resultsmentioning

confidence: 99%

Duration of the patient interval in breast cancer and factors associated with longer delays in low‐and middle‐income countries: A systematic review with meta‐analysis

et al. 2022

View full text Add to dashboard Cite

Objective: Breast cancer survival is lower in low-and middle-income countries (LMICs) partially due to many women being diagnosed with late-stage disease. The patient interval refers to the time elapsed between the detection of symptoms and the first consultation with a healthcare provider and is considered one of the core indicators for early diagnosis and treatment. The goal of the current research was to conduct a meta-analysis of the duration of the patient interval in LMICs and investigate the socio-demographic and socio-cultural factors related to longer delays in presentation. Methods:We conducted a systematic review with meta-analysis (pre-registered protocol CRD42020200752). We searched seven information sources (2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017)(2018)(2019)(2020)(2021)(2022) and included 50 articles reporting the duration of patient intervals for 18,014 breast cancer patients residing in LMICs. Results:The longest patient intervals were reported in studies from the Middle East (3-4 months), followed by South-East Asia (2 months), Africa (1-2 months), Latin America (1 month), and Eastern Europe (1 month). Older age, not being married, lower socio-economic status, illiteracy, low knowledge about cancer, disregarding symptoms or not attributing them to cancer, fear, negative beliefs about cancer, and low social support were related to longer delays across most regions. Longer delays were also related to use of alternative medicine in the Middle East, South-East Asia, and Africa and distrust in the healthcare system in Eastern Europe. Conclusions:There is large variation in the duration of patient intervals across LMICs in different geographical regions. Patient intervals should be reduced and, for this purpose, it is important to explore their determinants taking into account the social, cultural, and economic context.This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

show abstract

“…Delay in the diagnosis and treatment of BC is a major challenge that can lead to disease progression and develops mortality and also reduces the survival rate of patients; so; timely diagnosis of the disease is an important factor to prevent the mortality of BC. [ 5 ] BC screening is one of the best methods to decrease mortality through early diagnosis of disease. [ 6 ] There have been different methods recommended for BC screening, including mammography, Clinical Breast Exam (CBE), and Breast Self-Exam (BSE).…”

Section: Introductionmentioning

confidence: 99%